Thor Alvegård

Medicin och livsvetenskap

1. Sarcoma 100%
2. Osteosarcoma 36%
3. Neoplasm Metastasis 21%
4. Survival 19%
5. Ewing's Sarcoma 19%
6. Malignant Fibrous Histiocytoma 19%
7. Gastrointestinal Stromal Tumors 19%
8. Imatinib Mesylate 17%
9. Neoplasms 17%
10. Extremities 17%
11. Drug Therapy 16%
12. Recurrence 14%
13. Ifosfamide 14%
14. SSG IX protocol 12%
15. Sweden 10%
16. Doxorubicin 9%
17. Radiotherapy 7%
18. Methotrexate 7%
19. Cisplatin 7%
20. Synovial Sarcoma 7%
21. Referral and Consultation 7%
22. Ki-67 Antigen 6%
23. Survival Rate 6%
24. Therapeutics 6%
25. ATP Binding Cassette Transporter, Subfamily B, Member 1 5%
26. Costs and Cost Analysis 5%
27. Plasminogen Activators 5%
28. Whole-Body Irradiation 5%
29. Biopsy 5%
30. Urokinase-Type Plasminogen Activator 5%
31. Norway 5%
32. Needle Biopsy 5%
33. Gonadal Steroid Hormones 5%
34. Proliferating Cell Nuclear Antigen 5%
35. Abdominal Wall 5%
36. Oral Contraceptives 5%